Page 35 - உணர்ச்சி பல்கலைக்கழகம் இல் அட்லாண்டா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus. A pharmacy technician preparing a dose of the Pfizer vaccine in San Antonio.Credit.Tamir Kalifa for The New York Times July 8, 2021 Pfizer and BioNTech announced on Thursday that they were developing a version of the coronavirus vaccine that targets Delta, a highly contagious variant that has spread to nearly 100 countries. The companies expect to begin clinical trials of the vaccine in August. Pfizer and BioNTech also reported promising results from studies of people who received a third dose of the original vaccine. A booster given six months after the second dose of the vaccine increases the potency of antibodies against the original virus and the Beta variant by five- to tenfold, the companies said.

New yorkUnited statesBellevue hospital centerUnited kingdomCenters for diseaseEmory university in atlantaDrug administrationDisease controlNatalie deanEmory universityபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்பெல்வ்யூ மருத்துவமனை மையம்ஒன்றுபட்டது கிஂக்டம்மையங்கள் க்கு நோய்உணர்ச்சி பல்கலைக்கழகம் இல் அட்லாண்டா